Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia

Epidemiology and Infection

Volumn 141, Issue 8, 2013, Pages 1697-1704

  Elemraid, M A ^a,b   Rushton, S P ^c   Shirley, M D F ^c   Thomas, M F ^a,c   Spencer, D A ^a   Eastham, K M ^d   Hampton, F ^e   Gorton, R ^f   Pollard, K ^a   Gennery, A R ^a,b   Clark, J E ^a,b  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^e JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Children; incidence; pneumococcal conjugate vaccine; pneumonia

Indexed keywords

HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; RISK REDUCTION; SCHOOL CHILD; UNITED KINGDOM;

CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ENGLAND; HUMANS; INCIDENCE; INFANT; PNEUMOCOCCAL VACCINES; PNEUMONIA; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84880380259     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002257     Document Type: Article

References (35)

1. Harris M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011. Thorax 2011; 66 (Suppl. 2): Ii1-23.
2. Bryce J, et al. WHO estimates of the causes of death in children. Lancet 2005; 365: 1147-1152.
3. Rudan I, et al. Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization 2008; 86: 408-416.
4. Greenwood B. The epidemiology of pneumococcal infection in children in the developing world. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 1999; 354: 777-785.
5. Clements H, et al. Rationalised prescribing for community acquired pneumonia: A closed loop audit. Archives of Disease in Childhood 2000; 83: 320-324.
6. Drummond P, et al. Community acquired pneumonia - a prospective UK study. Archives of Disease in Childhood 2000; 83: 408-412.
7. Klugman KP, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New England Journal of Medicine 2003; 349: 1341-1348.
8. Cutts FT, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: Randomised, double-blind, placebo-controlled trial. Lancet 2005; 365: 1139-1146.
9. Black SB, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatric Infectious Disease Journal 2002; 21: 810-815.
10. Lucero MG, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database of Systematic Reviews 2009; Issue 4. Art. No. CD004977.
11. Pavia M, et al. Efficacy of pneumococcal vaccination in children younger than 24 months: A meta-analysis. Pediatrics 2009; 123: E1103-1110.
12. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiologic Reviews 1988; 10: 212-241.
13. Victora CG, Habicht JP, Bryce J. Evidence-based public health: Moving beyond randomized trials. American Journal of Public Health 2004; 94: 400-405.
14. Clark JE, et al. Epidemiology of community-acquired pneumonia in children seen in hospital. Epidemiology and Infection 2007; 135: 262-269.
15. Cherian T, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bulletin of the World Health Organization 2005; 83: 353-359.
16. World Health Organization Pneumonia Vaccine Trial Investigators Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Geneva, WHO 2001; WHO/V&B/01.35.
17. Enwere G, et al. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Tropical Medicine and International Health 2007; 12: 1377-1385.
18. British Thoracic Society. Guidelines for the management of community acquired pneumonia in childhood. Thorax 2002; 57 (Suppl. 1): I1-24.
19. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: A consensus statement. American Journal of Respiratory and Critical Care Medicine 1999; 159: 321-340.
20. Office for National Statistics (ONS). Population estimates for UK, England and Wales, Scotland and Northern Ireland: Mid year population estimates, 2009 (http://www.statistics.gov.uk/statbase/product.asp?vlnk= 15106). Accessed February 2012.
21. Jokinen C, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. American Journal of Epidemiology 1993; 137: 977-988.
22. Gortner L, et al. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: Results from the MOSAIC cohort. Neonatology 2011; 99: 112-117.
23. Koshy E, et al. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: National time-trends study, 1997-2008. Thorax 2010; 65: 770-774.
24. De Wals P, et al. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal 2008; 27: 963-968.
25. Lucero MG, et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: A randomized, double-blind, placebo-controlled trial. Pediatric Infectious Disease Journal 2009; 28: 455-462.
26. Hansen J, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: Updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatric Infectious Disease Journal 2006; 25: 779-781.
27. Grijalva CG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: A time-series analysis. Lancet 2007; 369: 1179-1186.
28. Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nature Medicine 2004; 10: 811-813.
29. Resti M, et al. Community-acquired bacteremic pneumococcal pneumonia in children: Diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clinical Infectious Diseases 2010; 51: 1042-1049.
30. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infectious Diseases 2005; 5: 83-93.
31. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-1556.
32. Garmendia J, Morey P, Bengoechea JA. Impact of cigarette smoke exposure on host-bacterial pathogen interactions. European Respiratory Journal 2012; 39: 467-477.
33. Hill SC, Liang L. Smoking in the home and children's health. Tobacco Control 2008; 17: 32-37.
34. Michelow IC, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113: 701-707.
35. Neuman MI, et al. Variability in the interpretation of chest radiographs for the diagnosis of pneumonia in children. Journal of Hospital Medicine 2012; 7: 294-298.